Reply to "Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection"
Microbiol Spectr
.
2024 Dec 16:e0197924.
doi: 10.1128/spectrum.01979-24.
Online ahead of print.
Authors
Jefferson M Jones
1
,
Melissa M Coughlin
1
,
Eduard Grebe
2
,
Michael P Busch
2
,
Kristie E N Clarke
3
Affiliations
1
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
2
Vitalant Research Institute, San Francisco, California, USA.
3
Office of Public Health Data, Surveillance, and Technology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
PMID:
39679675
DOI:
10.1128/spectrum.01979-24
No abstract available
Keywords:
SARS-CoV-2; serology; seroprevalence; serosurveillance; vaccines.